JP2023545359A5 - - Google Patents

Info

Publication number
JP2023545359A5
JP2023545359A5 JP2023515569A JP2023515569A JP2023545359A5 JP 2023545359 A5 JP2023545359 A5 JP 2023545359A5 JP 2023515569 A JP2023515569 A JP 2023515569A JP 2023515569 A JP2023515569 A JP 2023515569A JP 2023545359 A5 JP2023545359 A5 JP 2023545359A5
Authority
JP
Japan
Prior art keywords
cancer
adc
cell
pharmaceutical composition
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023515569A
Other languages
English (en)
Japanese (ja)
Other versions
JP7882839B2 (ja
JP2023545359A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/058273 external-priority patent/WO2022054009A2/en
Publication of JP2023545359A publication Critical patent/JP2023545359A/ja
Publication of JP2023545359A5 publication Critical patent/JP2023545359A5/ja
Application granted granted Critical
Publication of JP7882839B2 publication Critical patent/JP7882839B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023515569A 2020-09-12 2021-09-11 抗her2抗体-薬物複合体治療のためのスコアリング方法 Active JP7882839B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063077604P 2020-09-12 2020-09-12
US63/077,604 2020-09-12
PCT/IB2021/058273 WO2022054009A2 (en) 2020-09-12 2021-09-11 A scoring method for an anti-her2 antibody-drug conjugate therapy

Publications (3)

Publication Number Publication Date
JP2023545359A JP2023545359A (ja) 2023-10-30
JP2023545359A5 true JP2023545359A5 (cg-RX-API-DMAC7.html) 2024-09-11
JP7882839B2 JP7882839B2 (ja) 2026-06-30

Family

ID=77801755

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023515569A Active JP7882839B2 (ja) 2020-09-12 2021-09-11 抗her2抗体-薬物複合体治療のためのスコアリング方法

Country Status (10)

Country Link
US (1) US20240426826A1 (cg-RX-API-DMAC7.html)
EP (1) EP4211598B1 (cg-RX-API-DMAC7.html)
JP (1) JP7882839B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230066094A (cg-RX-API-DMAC7.html)
CN (1) CN116601713A (cg-RX-API-DMAC7.html)
AU (2) AU2021340002B9 (cg-RX-API-DMAC7.html)
CA (1) CA3195062A1 (cg-RX-API-DMAC7.html)
ES (1) ES3064041T3 (cg-RX-API-DMAC7.html)
IL (1) IL301265A (cg-RX-API-DMAC7.html)
WO (1) WO2022054009A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025525054A (ja) * 2022-07-28 2025-08-01 アプライド マテリアルズ インコーポレイテッド 自動her2スコアリングのための方法およびシステム
EP4623936A1 (en) * 2022-11-22 2025-10-01 Keymed Biosciences (Chengdu) Co., Ltd. Fused ring compound, conjugate thereof and use thereof
TW202540115A (zh) * 2023-11-16 2025-10-16 大陸商上海齊魯製藥研究中心有限公司 一種氘代喜樹鹼化合物及其製備和應用
WO2025162211A1 (zh) * 2024-01-29 2025-08-07 正大天晴药业集团股份有限公司 抗her2抗体药物偶联物治疗胃癌的用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
JP4334141B2 (ja) 1998-04-20 2009-09-30 グリカート バイオテクノロジー アクチェンゲゼルシャフト 抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作
CN103333860B (zh) 2000-10-06 2015-07-08 协和发酵麒麟株式会社 产生抗体组合物的细胞
WO2013181571A2 (en) * 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to trastuzumab
SG11201603960XA (en) 2014-01-31 2016-07-28 Daiichi Sankyo Co Ltd Anti-her2 antibody-drug conjugate
GB201502590D0 (en) * 2015-02-16 2015-04-01 Lonza Ag Method and apparatus for designing proteins
EP3304079B1 (en) * 2015-06-03 2020-06-03 Bristol-Myers Squibb Company Anti-gitr antibodies for cancer diagnostics
BR112019018307A2 (pt) * 2017-03-03 2020-03-31 Treos Bio Zrt Plataforma para identificação de peptídeos imunogênicos baseada em população
WO2019020556A1 (en) * 2017-07-24 2019-01-31 Ventana Medical Systems, Inc. METHODS AND SYSTEMS FOR ASSESSING INFILTRAT OF IMMUNE CELLS IN TUMOR SAMPLES
EP3721373B1 (en) * 2017-12-07 2025-03-05 Ventana Medical Systems, Inc. Deep-learning systems and methods for joint cell and region classification in biological images
EP3797296B1 (en) * 2018-05-21 2024-09-04 Genentech, Inc. Her2 heterogeneity as a biomarker in cancer
US11030744B2 (en) * 2018-06-26 2021-06-08 Astrazeneca Computational Pathology Gmbh Deep learning method for tumor cell scoring on cancer biopsies
WO2020023213A1 (en) 2018-07-27 2020-01-30 Ventana Medical Systems, Inc. Systems for automated in situ hybridization analysis
US20240301512A1 (en) * 2021-01-29 2024-09-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of assessing the risk of developing progressive multifocal leukoencephalopathy in patients treated with vla-4 antagonists

Similar Documents

Publication Publication Date Title
Goetz et al. In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor
Moore et al. Effects of an unlabeled loading dose on tumor-specific uptake of a fluorescently labeled antibody for optical surgical navigation
JP5586368B2 (ja) 腫瘍マーカーとしてのn1,n12−ジアセチルスペルミン
Li et al. In vivo molecular imaging of gastric cancer by targeting MG7 antigen with confocal laser endomicroscopy
AU2019376078A1 (en) CDCP1-targeted therapies
JP2025509564A5 (cg-RX-API-DMAC7.html)
JP2023545096A5 (cg-RX-API-DMAC7.html)
RU2750817C1 (ru) Применение конъюгата анти-her2 антитело-лекарственное средство при лечении уротелиальной карциномы
IL273252B2 (en) Compositions and methods for predicting response to napi2b-targeted therapy
CN116601713A (zh) 用于抗her2抗体-药物缀合物疗法的评分方法
JP2024545428A5 (cg-RX-API-DMAC7.html)
JP2019524706A5 (cg-RX-API-DMAC7.html)
JPWO2020040245A5 (cg-RX-API-DMAC7.html)
JP2023542301A5 (cg-RX-API-DMAC7.html)
JP2025509564A (ja) 抗trop2抗体-薬物コンジュゲート治療のためのスコアリング方法
CN107949385B (zh) 荧光缀合物
JP2025503511A5 (cg-RX-API-DMAC7.html)
Liu et al. Enhanced visualization of colonic polyps using a fluorophore-conjugated claudin-1 antibody in a CPC-APC mouse model
WO2025055589A1 (en) Methods of treating cervical cancer using anti-her2 antibody-drug conjugates
CN113754764B (zh) 抗dog-1抗体、缀合物、药物组合物、药物制剂及其用途
CN120053679A (zh) 一种靶向CD66c的抗体偶联药物及其在制备胃食管结合部癌治疗药物中的用途
Zonoobi Nei enhuis
CN116930494A (zh) Icam1或其编码基因在制备宫颈癌治疗或诊断产品中的用途
Lauwerends Zweedi k, BE, Galema, H.., Nei enhuis, LK
WO2025095142A1 (ja) 光免疫療法